Selected Publications |
- Yaffe K, Vittinghoff E, Ensrud KE, Johnson KC, Diem S, Hanes V, Grady D. Effects of ultra-low-dose transdermal estradiol on cognition and health-related quality of life. Arch Neurol. 2006;63(7):945–950. doi:10.1001/archneur.63.7.945
- Yaffe K, Krueger K, Cummings SR, et al. Effect of raloxifene on prevention of dementia and cognitive impairment in older women: the Multiple Outcomes of Raloxifene Evaluation (MORE) randomized trial. Am J Psychiatry. 2005;162(4):683–690. doi:10.1176/appi.ajp.162.4.683
- Grady D, Yaffe K, Kristof M, Lin F, Richards C, Barrett-Connor E. Effect of postmenopausal hormone therapy on cognitive function: the Heart and Estrogen/progestin Replacement Study. Am J Med. 2002;113(7):543–548. doi:10.1016/s0002-9343(02)01270-6
- Barnes DE, Balderson BH, Shulman L, Rosenberg DE, Matson TE, Mettert KD, Delaney K, King D, Adams K, Fleckenstein L, Peltz CB, Idu A, Larson EB, Yaffe K, Dublin S. The Systematic Multi-domain Alzheimer's Risk Reduction Trial (SMARRT) intervention: A personalized approach to dementia risk reduction. J Alzheimers Dis. 2024 Dec;102(4):1121-1132. doi: 10.1177/13872877241296161. Epub 2024 Dec 3. PMID: 39623940; PMCID: PMC11875122.
- Yaffe K, Vittinghoff E, Dublin S, et al. Effect of Personalized Risk-Reduction Strategies on Cognition and Dementia Risk Profile Among Older Adults: The SMARRT Randomized Clinical Trial. JAMA Intern Med. 2024;184(1):54–62. doi:10.1001/jamainternmed.2023.6279
- Brenowitz WD, Yaffe K. Observational studies in Alzheimer disease: bridging preclinical studies and clinical trials. Nat Rev Neurol. 2022 Dec;18(12):747-757.
- Anstey KJ, Peters R, Zheng L, Barnes DE, Brayne C, Brodaty H, Chalmers J, Clare L, Dixon RA, Dodge H, Lautenschlager NT, Middleton LE, Qiu C, Rees G, Shahar S, Yaffe K. Future Directions for Dementia Risk Reduction and Prevention Research: An International Research Network on Dementia Prevention Consensus. J Alzheimers Dis. 2020;78(1):3-12.
- Marcum ZA, Rosenberg D, Barnes DE, Yaffe K, Larson EB. Engaging Patients to Design the Systematic Multi-Domain Alzheimer's Risk Reduction Trial (SMARRT) Intervention: Findings from a Web-Based Survey. J Alzheimers Dis Rep. 2020 Jul 23;4(1):255-260.
- Yaffe K, Barnes DE, Rosenberg D, Dublin S, Kaup AR, Ludman EJ, Vittinghoff E, Peltz CB, Renz AD, Adams KJ, Larson EB. Systematic Multi-Domain Alzheimer's Risk Reduction Trial (SMARRT): Study Protocol. J Alzheimers Dis. 2019;70(s1):S207-S220.
- Committee on the Public Health Dimensions of Cognitive Aging; Board on Health Sciences Policy; Institute of Medicine. Cognitive Aging: Progress in Understanding and Opportunities for Action. Blazer DG, Yaffe K, Liverman CT, editors. Washington (DC): National Academies Press (US); 2015 Jul 21.
- Barnes DE, Santos-Modesitt W, Poelke G, Kramer AF, Castro C, Middleton LE, Yaffe K. The Mental Activity and eXercise (MAX) trial: a randomized controlled trial to enhance cognitive function in older adults. JAMA Intern Med. 2013 May 13;173(9):797-804.
- Yaffe K, Krueger K, Sarkar S, Grady D, Barrett-Connor E, Cox DA, Nickelsen T; Multiple Outcomes of Raloxifene Evaluation Investigators. Cognitive function in postmenopausal women treated with raloxifene. N Engl J Med. 2001 Apr 19;344(16):1207-13.